Annual Registration Fees Proposed For Firms Across FDA’s Regulatory Range

Leading House Democrats plan to expedite hearings on draft legislation to comprehensively strengthen FDA's global safety oversight for food, drug and cosmetic products, with a Health Subcommittee hearing scheduled April 24